Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v1-EN
Language English English
Date Updated 2023-01-12 2022-12-07
Drug Identification Number 02241497 02241497
Brand name VENTOLIN HFA VENTOLIN HFA
Common or Proper name salbutamol pressurised inhalation, suspension salbutamol pressurised inhalation, suspension
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SALBUTAMOL SALBUTAMOL
Strength(s) 100MCG 100MCG
Dosage form(s) METERED-DOSE AEROSOL METERED-DOSE AEROSOL
Route of administration INHALATION INHALATION INHALATION INHALATION
Packaging size 1x200 1x200
ATC code R03AC R03AC
ATC description ADRENERGICS, INHALANTS ADRENERGICS, INHALANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-12-01 2022-12-01
Estimated end date 2023-02-01 2023-01-06
Actual end date 2023-01-11
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Inventory on allocation to support demand. Inventory on allocation to support demand.
Health Canada comments